Research Article

Small Fiber Neuropathy Associated with Hyperlipidemia: Utility of Cutaneous Silent Periods and Autonomic Tests

Table 2

CSP latency and duration measured from upper and lower extremities of patients and controls groups.

CSP (ms)Patient group
( )
mean ± SD
Control group
( )
mean ± SD
value

Upper extremity
 Latency 0.034 *
 Duration 0.039 *
Lower extremity
 Latency 0.103
 Duration 0.001 *

SD: standard deviation; CSP: cutaneous silent period, .